Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 15Breast 11Thoracic 7Head & Neck 7Gastrointestinal 7Other hematologic neoplasm 6Genitourinary 5Gynecologic 3Plasma cell 2Endocrine 2Dermatologic 2CNS 2Sarcoma 1Other 1Myeloid 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1

Interventions

Cyclophosphamide 168Rituximab 161Specimen Handling 115Biopsy 91Magnetic Resonance Spectroscopy 89Vincristine 84Doxorubicin 78Prednisone 75fludarabine 71venetoclax 69obinutuzumab 62ibrutinib 55Lenalidomide 55Dexamethasone 55Cytarabine 48Methotrexate 47acalabrutinib 43Etoposide 41CT-P10 41blinatumomab 40fludarabine phosphate 35Gemcitabine 33Bendamustine Hydrochloride 33zanubrutinib 31pembrolizumab 30glofitamab 30Calcium Dobesilate 30prednylidene 29deltacortene 28Nivolumab 27

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interviews as Topic × Lymphoid × 90 days × Clear all
NCT06323044 2026-03-24

MedSupport Intervention to Identify and Address Barriers to Pediatric Medication Adherence

Roswell Park Cancer Institute

Phase NA Recruiting
150 enrolled
LymphoidOther hematologic neoplasm

Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡